Top 5 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margins (QLTI, PDLI, TECH, GILD, AMGN)
Below are the top 5 biotechnology stocks on the NASDAQ in terms of profit margins.
QLT (NASDAQ: QLTI) has the trailing-twelve-month profit margins of 230.56%. QLTI’s quarterly earnings growth stands at 161.60% year-over-year.
PDL BioPharma Inc (NASDAQ: PDLI) has the trailing-twelve-month profit margins of 56.11%. The PEG ratio of PDLI is 0.21.
Techne Corp (NASDAQ: TECH) has the trailing-twelve-month profit margins of 40.89%. TECH’s trailing-twelve-month operating margins stand at 57.57%.
Gilead Sciences Inc (NASDAQ: GILD) has the trailing-twelve-month profit margins of 38.35%. Morgan Joseph upgraded GILD from “sell” to “hold.”
Amgen Inc (NASDAQ: AMGN) has the trailing-twelve-month profit margins of 31.84%. AMGN’s trailing-twelve-month operating margins stand at 38.56%.
Read more from Benzinga's Company news.
Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.
